| P2093 | author name string | Marco Falcone | |
| | Alessandro Russo | |
| | Francesco Menichetti | |
| | Giusy Tiseo | |
| P2860 | cites work | β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3) | Q26825753 |
| | Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent | Q28082019 |
| | The clinical spectrum of pulmonary aspergillosis | Q28204537 |
| | Pathophysiology and immunology of allergic bronchopulmonary aspergillosis | Q28268103 |
| | Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia | Q28284944 |
| | Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma | Q28286684 |
| | Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria | Q28295337 |
| | Invasive aspergillosis in the intensive care unit | Q28306909 |
| | Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole | Q33535204 |
| | Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response | Q33696043 |
| | Aspergillus PCR: one step closer to standardization. | Q33769584 |
| | Factors associated with mortality in transplant patients with invasive aspergillosis | Q33867013 |
| | Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review | Q34230722 |
| | PCR in diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance | Q34298192 |
| | Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies | Q34301513 |
| | Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation | Q34368144 |
| | Diagnosis and treatment of allergic bronchopulmonary aspergillosis | Q34371628 |
| | Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America | Q34532546 |
| | Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis | Q34674620 |
| | Causes of death in a contemporary cohort of patients with invasive aspergillosis | Q35213770 |
| | Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients | Q35575320 |
| | Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. | Q35668212 |
| | Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis | Q36118619 |
| | Electronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study. | Q36826800 |
| | Invasive aspergillosis in chronic granulomatous disease | Q37417628 |
| | Invasive aspergillosis in patients with liver disease | Q37812386 |
| | Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis | Q37878272 |
| | Pulmonary aspergilloma: clinical aspects and surgical treatment outcome | Q38025795 |
| | Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis | Q38120032 |
| | Chronic pulmonary aspergillosis. | Q38168300 |
| | Allergic aspergillosis of the respiratory tract | Q38193047 |
| | Aspergilloma and the surgeon | Q38195606 |
| | Current challenges in the microbiological diagnosis of invasive aspergillosis | Q38221673 |
| | Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis | Q38981774 |
| | Invasive mould infections in the ICU setting: complexities and solutions | Q39206915 |
| | Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases. | Q39367515 |
| | Comparison between PCR and detection of antigen in sera for diagnosis of pulmonary aspergillosis | Q39445900 |
| | Clinical validity of bis(methylthio)gliotoxin for the diagnosis of invasive aspergillosis | Q40201199 |
| | The current management landscape: aspergillosis | Q40438379 |
| | Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management | Q40859210 |
| | Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial | Q40865179 |
| | Predictors of mortality in non-neutropenic patients with invasive pulmonary aspergillosis: does galactomannan have a role? | Q42209012 |
| | A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis | Q42621528 |
| | Efficacy and safety of posaconazole for chronic pulmonary aspergillosis | Q42835533 |
| | Posaconazole for Chronic Pulmonary Aspergillosis: The Next Strategy against the Threat of Azole‐ResistantAspergillusInfection | Q42835536 |
| | Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study | Q43631437 |
| | Comparison of a novel Aspergillus lateral-flow device and the Platelia® galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation. | Q45366904 |
| | When to suspect and work up allergic bronchopulmonary aspergillosis | Q45733422 |
| | Serum galactomannan antigen test for the diagnosis of chronic pulmonary aspergillosis. | Q45982414 |
| | Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis. | Q46009116 |
| | A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients | Q46059175 |
| | The Management of Chronic Pulmonary Aspergillosis: The UK National Aspergillosis Centre Approach | Q47130266 |
| | Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis | Q47169634 |
| | Detection of (1, 3)-β-D-glucan in bronchoalveolar lavage and serum samples collected from immunocompromised hosts | Q47192822 |
| | Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review. | Q49604618 |
| | A Randomized Trial of Itraconazole vs Prednisolone in Acute-Stage Allergic Bronchopulmonary Aspergillosis Complicating Asthma | Q50055346 |
| | Novel immunologic classification of aspergillosis in adult cystic fibrosis. | Q50946631 |
| | Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience. | Q51000077 |
| | A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility. | Q51035901 |
| | Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. | Q51149137 |
| | Clinical characteristics and prognosis of chronic pulmonary aspergillosis. | Q51173069 |
| | A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. | Q52988265 |
| | Allergic Bronchopulmonary Aspergillosis | Q57749833 |
| | Bis(methyl)gliotoxin proves to be a more stable and reliable marker for invasive aspergillosis than gliotoxin and suitable for use in diagnosis | Q58839876 |
| | Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUN gal infections Definitions in ICU patients ( FUNDICU ) project | Q64027938 |
| | What’s new in invasive pulmonary aspergillosis in the critically ill | Q64131454 |
| | Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey | Q80052810 |
| | Invasive aspergillosis in critically ill patients without malignancy | Q80269940 |
| | β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis | Q83514901 |
| | The spectrum of pulmonary aspergillosis | Q90576775 |
| | Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium | Q91699004 |
| | Diagnostic Value of Galactomannan in Bronchoalveolar Lavage Fluid for Chronic Respiratory Disease with Pulmonary Aspergillosis | Q92667343 |
| | Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: a systematic review with qualitative evidence synthesis | Q93208401 |
| | COVID-19 Associated Pulmonary Aspergillosis | Q93256441 |
| | Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper | Q94557146 |
| P577 | publication date | 2020-07-07 | |
| P1433 | published in | Infectious diseases and therapy | Q26842457 |
| P1476 | title | Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment | |